These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Variant type von Willebrand disease with defective binding to factor VIII]. Shima M. Ryoikibetsu Shokogun Shirizu; 1998; (21 Pt 2):430-3. PubMed ID: 9833534 [No Abstract] [Full Text] [Related]
3. Update on the management of von Willebrand disease. Federici AB. Clin Adv Hematol Oncol; 2008 Jan; 6(1):29-30. PubMed ID: 18322438 [No Abstract] [Full Text] [Related]
4. Acquired von Willebrand syndrome: an update. Franchini M, Lippi G. Am J Hematol; 2007 May; 82(5):368-75. PubMed ID: 17133419 [Abstract] [Full Text] [Related]
10. Acquired von Willebrand syndrome: is it an extremely rare disorder or do we see only the tip of the iceberg? Federici AB. J Thromb Haemost; 2008 Apr; 6(4):565-8. PubMed ID: 18221357 [No Abstract] [Full Text] [Related]
11. Acquired von Willebrand syndrome: experience from 2 years in a single laboratory compared with data from the literature and an international registry. Budde U, Bergmann F, Michiels JJ. Semin Thromb Hemost; 2002 Apr; 28(2):227-38. PubMed ID: 11992245 [Abstract] [Full Text] [Related]
12. Acquired von Willebrand syndromes: clinical features, aetiology, pathophysiology, classification and management. Michiels JJ, Budde U, van der Planken M, van Vliet HH, Schroyens W, Berneman Z. Best Pract Res Clin Haematol; 2001 Jun; 14(2):401-36. PubMed ID: 11686107 [Abstract] [Full Text] [Related]
13. Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With von Willebrand disease type 1, 2 and 3. Michiels JJ, van Vliet HH, Berneman Z, Gadisseur A, van der Planken M, Schroyens W, van der Velden A, Budde U. Clin Appl Thromb Hemost; 2007 Jan; 13(1):14-34. PubMed ID: 17164493 [Abstract] [Full Text] [Related]
14. [Acquired von Willebrand syndrome]. de Lange DW, Fijnheer R, Wittebol S. Ned Tijdschr Geneeskd; 2003 Sep 13; 147(37):1808-11. PubMed ID: 14526622 [Abstract] [Full Text] [Related]
15. Managing patients with von Willebrand disease type 1, 2 and 3 with desmopressin and von Willebrand factor-factor VIII concentrate in surgical settings. Michiels JJ, van Vliet HH, Berneman Z, Schroyens W, Gadisseur A. Acta Haematol; 2009 Sep 13; 121(2-3):167-76. PubMed ID: 19506363 [Abstract] [Full Text] [Related]
16. Von Willebrand factor/factor VIII concentrates in the treatment of von Willebrand disease. Batlle J, López-Fernández MF, Fraga EL, Trillo AR, Pérez-Rodríguez MA. Blood Coagul Fibrinolysis; 2009 Mar 13; 20(2):89-100. PubMed ID: 19786936 [Abstract] [Full Text] [Related]
17. Acquired von Willebrand syndrome: features and management. Mohri H. Am J Hematol; 2006 Aug 13; 81(8):616-23. PubMed ID: 16823821 [Abstract] [Full Text] [Related]
18. Molecular basis of von Willebrand disease and its clinical implications. Haematologica; 2004 Sep 13; 89(9):1036. PubMed ID: 15377463 [No Abstract] [Full Text] [Related]
19. Acquired von Willebrand syndrome: its pathophysiology, laboratory features and management. Mohri H. J Thromb Thrombolysis; 2003 Jun 13; 15(3):141-9. PubMed ID: 14739623 [Abstract] [Full Text] [Related]
20. Prophylaxis in von Willebrand disease. Franchini M, Targher G, Lippi G. Ann Hematol; 2007 Oct 13; 86(10):699-704. PubMed ID: 17634944 [Abstract] [Full Text] [Related] Page: [Next] [New Search]